Clinical Trial Billing Under Medicare How the New National Coverage Decision Will Impact You
Product Details
Held Feb. 1, 2007
Alert:
The Centers for Medicare and Medicaid Services (CMS) has announced plans to issue a revised National Coverage Decision (NCD) by April 2007.
Sponsors must understand the current NCD and the revisions that are under way when they design a study to determine study budgets and to effectively and accurately bill Medicare for expenses. Sites must understand the NCD as they are primarily responsible for making sure Medicare billing rules are followed.
The penalties for submitting inaccurate claims to Medicare are exorbitant — from steep fines to possible criminal prosecution under the False Claims Act.
In this special 105-minute extended length audio CD/transcript noted attorney Mark Barnes will provide the information you need to receive reimbursement from the CMS for clinical trial expenses without running afoul of the Office of Inspector General. This will include:
- An explanation of the current, and still applicable, Medicare NCD
- Compliance issues you are likely to face
- Enforcement actions the government can, and has, undertaken
- The initiatives under development by the CMS to revise the NCD
- Changes that are likely to be made when the new NCD is released
Avoid fines and penalties. Discover when you can and cannot bill Medicare — now and in the future — when negotiating clinical trial budgets.
Order now for your entire team to listen in and discover:
- In plain language what the NCD says, what it will soon say and how it applies to them
- The recent Medicare clinical trials coverage initiatives, including proposed changes and expected time frames
- How Medicare coverage rules compare to Medicaid and private payers' coverage rules
- The most common coverage misconceptions and likely areas of government scrutiny
- Why a Medicare billing analysis of clinical trial services is key for sponsors drafting and negotiating a trial budget and planning a clinical trial
- Why research sites have great difficulty in billing appropriately for services they give to subjects in clinical trials, and why sponsors should care
- What to consider when coordinating clinical trial budgets, clinical trial agreements, protocols and informed consent forms